Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tivic Health Systems (TIVC) Gains from Sales and Divestitures (2021 - 2025)

Tivic Health Systems (TIVC) has 4 years of Gains from Sales and Divestitures data on record, last reported at $32788.0 in Q3 2025.

  • For Q3 2025, Gains from Sales and Divestitures rose 774.35% year-over-year to $32788.0; the TTM value through Sep 2025 reached $32788.0, up 774.35%, while the annual FY2024 figure was $331.0, N/A changed from the prior year.
  • Gains from Sales and Divestitures reached $32788.0 in Q3 2025 per TIVC's latest filing, up from $111.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $32788.0 in Q3 2025 and bottomed at $71.0 in Q4 2022.
  • Average Gains from Sales and Divestitures over 4 years is $6531.7, with a median of $3750.0 recorded in 2024.
  • Peak YoY movement for Gains from Sales and Divestitures: tumbled 99.39% in 2022, then skyrocketed 774.35% in 2025.
  • A 4-year view of Gains from Sales and Divestitures shows it stood at $11719.0 in 2021, then crashed by 99.39% to $71.0 in 2022, then skyrocketed by 366.2% to $331.0 in 2024, then skyrocketed by 9805.74% to $32788.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Sales and Divestitures were $32788.0 in Q3 2025, $111.0 in Q2 2025, and $111.0 in Q1 2025.